ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,513Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 252

$1.39M Total Retail Price of All Prescriptions

Rank: 3 out of 252

741 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 741 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 741 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 18,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LOVASTATIN 875 737 1 39
FUROSEMIDE 712 617 2 7
LEVOTHYROXINE SODIUM 703 641 3 1
OMEPRAZOLE 647 471 4 6
AMLODIPINE BESYLATE 604 529 5 4
HYDROCHLOROTHIAZIDE 575 449 6 13
LISINOPRIL 518 407 7 3
HYDROCODONE-ACETAMINOPHEN 494 283 S3 8 5
POTASSIUM CHLORIDE 468 360 9 8
DONEPEZIL HCL 434 425 10 28
ZETIA 390 294 11 97
SIMVASTATIN 343 278 12 2
ATORVASTATIN CALCIUM 340 320 13 16
CRESTOR 334 243 14 34
ATENOLOL 327 238 15 18
EVISTA 314 288 16 91
CITALOPRAM HBR 313 271 17 15
MELOXICAM 301 232 18 20
TRAMADOL HCL 276 190 19 17
WARFARIN SODIUM 276 210 19 14
PRAVASTATIN SODIUM 276 195 19 12
METFORMIN HCL 271 205 22 9
GLIPIZIDE 263 244 23 52
GABAPENTIN 255 204 24 11
HYDRALAZINE HCL 229 212 25 95
MIRTAZAPINE 228 163 26 58
FENOFIBRATE 223 172 27 64
TAMSULOSIN HCL 211 199 28 26
CLOPIDOGREL 203 185 29 29
GUANFACINE HCL 200 190 R 30 166
TRIAMTERENE-HCTZ 198 150 31 33
ZOLPIDEM TARTRATE 198 131 31 21
TRAZODONE HCL 191 142 33 31
CARVEDILOL 190 165 34 22
POLYETHYLENE GLYCOL 3350 187 165 35 67
LOSARTAN-HYDROCHLOROTHIAZIDE 187 157 35 49
METOPROLOL TARTRATE 182 164 37 10
CYMBALTA 174 101 38 45
NEXIUM 159 96 39 23
CARBIDOPA-LEVODOPA 157 136 40 107
LOSARTAN POTASSIUM 157 123 40 24
CELEBREX 153 124 42 101
PLAVIX 152 141 43 43
VERAPAMIL ER 147 87 44 83
ISOSORBIDE MONONITRATE ER 144 142 45 50
PROPRANOLOL HCL 139 106 46 111
SINGULAIR 138 114 47 100
SPIRONOLACTONE 137 128 48 53
METOPROLOL SUCCINATE 133 116 49 19
FLUTICASONE PROPIONATE 128 89 50 36
DILTIAZEM ER 126 121 51 86
ACEBUTOLOL HCL 123 123 52 277
ALLOPURINOL 122 102 53 30
NAPROXEN 113 62 54 96
LABETALOL HCL 113 103 54 150
FAMOTIDINE 113 95 54 59
ALENDRONATE SODIUM 110 96 57 32
LANTUS SOLOSTAR 109 74 58 109
VYTORIN 106 106 59 218
CARISOPRODOL 105 40 R 60 70
NAMENDA 104 96 61 41
ESCITALOPRAM OXALATE 104 84 61 56
AMLODIPINE BESYLATE-BENAZEPRIL 104 97 61 60
DIOVAN 102 98 64 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 79 65 25
PAROXETINE HCL 93 51 66 75
PEN NEEDLE 91 55 67 140
PHENYTOIN SODIUM EXTENDED 90 43 68 103
SYNTHROID 88 88 69 47
MONTELUKAST SODIUM 87 68 70 153
TERAZOSIN HCL 86 36 71 94
DOXEPIN HCL 85 68 72 179
DIOVAN HCT 85 72 72 65
DIGOXIN 83 79 74 44
NIFEDIPINE ER 82 61 75 108
NIASPAN 80 80 76 167
AMITRIPTYLINE HCL 75 38 R 77 46
LYRICA 74 34 78 66
NITROSTAT 73 61 79 189
SERTRALINE HCL 72 59 80 27
CEPHALEXIN 72 57 80 121
FLUOXETINE HCL 71 41 82 57
PREMARIN 70 42 R 83 116
COMBIVENT 70 46 83 123
GEMFIBROZIL 70 45 83 98
INSULIN SYRINGE 68 51 86 93
PREDNISONE 68 66 86 42
BYSTOLIC 67 59 88 99
INDAPAMIDE 66 66 89 201
BYETTA 66 29 89 315
LANTUS 65 54 91 55
PRAMIPEXOLE DIHYDROCHLORIDE 64 31 92 163
TRAMADOL HCL-ACETAMINOPHEN 62 26 93 133
DOXAZOSIN MESYLATE 61 61 94 73
KLOR-CON M20 61 45 94 69
ESTRADIOL 60 50 R 96 76
PANTOPRAZOLE SODIUM 58 32 97 62
FOSINOPRIL SODIUM 58 46 97 182
TOPIRAMATE 58 36 97 151
CLONIDINE HCL 58 44 97 35
PINDOLOL 57 57 101 342
PRADAXA 55 51 102 285
SPIRIVA 55 47 102 68
WELCHOL 55 35 102 228
VENLAFAXINE HCL ER 55 20 102 105
RAMIPRIL 55 50 102 71
NOVOLOG 52 27 107 106
QUETIAPINE FUMARATE 51 33 108 77
CYCLOBENZAPRINE HCL 51 24 R 108 51
JANUVIA 50 24 110 88
CIPROFLOXACIN HCL 50 40 110 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.